BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 27044796)

  • 1. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
    Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
    Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.
    Pierce DA; Williamson JC; Mauck VS; Russell GB; Palavecino E; Burkart JM
    Perit Dial Int; 2012; 32(5):525-30. PubMed ID: 22302770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
    Davenport A;
    J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
    Chen SS; Sheth H; Piraino B; Bender F
    Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections.
    Chu KH; Choy WY; Cheung CC; Fung KS; Tang HL; Lee W; Cheuk A; Yim KF; Chan WH; Tong KL
    Perit Dial Int; 2008; 28(5):505-8. PubMed ID: 18708544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
    McQuillan RF; Chiu E; Nessim S; Lok CE; Roscoe JM; Tam P; Jassal SV
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
    Tsai CC; Yang PS; Liu CL; Wu CJ; Hsu YC; Cheng SP
    Am J Surg; 2018 Jan; 215(1):179-185. PubMed ID: 28341139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.
    Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK; Dash SC; Kumar P
    Perit Dial Int; 2005; 25(5):473-7. PubMed ID: 16178481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
    Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
    Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
    Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.
    Aykut S; Caner C; Ozkan G; Ali C; Tugba A; Zeynep G; Taner C
    Ren Fail; 2010 Jan; 32(3):356-61. PubMed ID: 20370452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
    Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.